Table 1 The clinic- pathological features of patients with pituitary adenoma
Parameter | Groups | Pituitary adenoma (n = 55) | Non-Functional pituitary adenoma (n = 25) | Functional pituitary adenoma (n = 30) | Acromegaly (n = 17) | Cushing (n = 13) |
|---|---|---|---|---|---|---|
Age (Years) | 20–40 | 27 (49.09%) | 11 (44%) | 15 (50%) | 9 (52.94%) | 7 (53.84%) |
40–60 | 17 (30.9%) | 7 (28%) | 10 (33.33%) | 5 (29.41%) | ||
60≤ | 11 (20%) | 7 (28%) | 5 (16.66%) | 3 (17.64%) | 5 (38.46%) | |
1 (7.69%) | ||||||
Gender | Female | 26 (47.27%) | 9 (36%) | 19 (63.33%) | 9 (52.94%) | 8 (61.53%) |
Male | 29 (52.72%) | 16 (64%) | ||||
| Â | Â | Â | 11 (36.66%) | 8 (47.05%) | 5 (38.46%) | |
Tumor invasiveness | Invasive | 25 (45.45%) | 10 (40%) | 13 (43.43%) | 9 (52.94%) | 4 (30.76%) |
Non- Invasive | 30 (54.54%) | 15 (60%) | 17 (56.56%) | 8 (47.05%) | 9 (69.23%) | |
Tumor size | Micro-Adenoma | 11 (20%) | 0 | 13 (43.43%) | 5 (29.41%) | 8 (61.53%) |
Macro-Adenoma | 44 (80%) | 25 (100%) | 17 (56.56%) | 12 (70.58%) | 5 (38.46%) |